Compare Vaxcyte Inc. Common Stock (PCVX) vs StoneX Group Inc. Common Stock (SNEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs StoneX Group Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while StoneX Group Inc. Common Stock trades at $59.51 (market cap $7.27B). The key difference: Vaxcyte Inc. Common Stock is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, StoneX Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and StoneX Group Inc. Common Stock for 0 Days on average.
| PCVX | SNEX | |
|---|---|---|
Market Cap | $10.51B | $7.27B |
Volume | 2,644,694 | 1,624,795 |
Sector | Health | Financials |
52-Week High | $73.82 | $92.67 |
52-Week Low | $40.32 | $37.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $28.28B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About StoneX Group Inc. Common Stock
StoneX Group Inc. is a financial services firm providing trading, clearing, execution, and cross-border payment services to institutional, commercial, and self-directed retail clients across global markets.
Read more on SNEX →
